Fig. 3.
Fig. 3. Time-course of PI3K activation in human eosinophils treated with IL-5 and PAF. Eosinophils (1.5 × 106) were treated with (A) IL-5 (10−9 mol/L) or (B) PAF (10−6 mol/L) at 37°C for the indicated time intervals. After cell lysis and immunoprecipitation, PI3K activity was detected as previously described.

Time-course of PI3K activation in human eosinophils treated with IL-5 and PAF. Eosinophils (1.5 × 106) were treated with (A) IL-5 (10−9 mol/L) or (B) PAF (10−6 mol/L) at 37°C for the indicated time intervals. After cell lysis and immunoprecipitation, PI3K activity was detected as previously described.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal